Table 3 Associations of two polymorphisms in the CD160 gene with AITD before and after adjusting for confounders
From: Associations between CD160 polymorphisms and autoimmune thyroid disease: a case-control study
Comparison models | Unadjusted estimates | Adjusted estimatesa | ||
|---|---|---|---|---|
OR (95%CI) | P values | OR (95%CI) | P values | |
rs744877 | ||||
Allele Model | 0.88 (0.77–1.01) | 0.069 | 0.88 (0.76–1.01) | 0.066 |
Dominant Model | 0.79 (0.66–0.95) | 0.013 | 0.78 (0.65–0.95) | 0.011 |
Recessive model | 1.02 (0.75–1.37) | 0.909 | 1.03 (0.76–1.40) | 0.864 |
Homozygous model | 0.89 (0.65–1.23) | 0.489 | 0.90 (0.65–1.24) | 0.528 |
Additive model | 0.77 (0.64–0.94) | 0.008 | 0.76 (0.63–0.93) | 0.007 |
rs3766526 | ||||
Allele Model | 1.12 (0.95–1.32) | 0.185 | 1.12 (0.94–1.32) | 0.197 |
Dominant Model | 1.11 (0.91–1.34) | 0.305 | 1.10 (0.90–1.34) | 0.354 |
Recessive model | 1.42 (0.85–2.37) | 0.182 | 1.49 (0.88–2.52) | 0.138 |
Homozygous model | 1.45 (0.86–2.44) | 0.159 | 1.51 (0.89–2.57) | 0.126 |
Additive model | 1.07 (0.88–1.31) | 0.484 | 1.06 (0.86–1.30) | 0.579 |